Related Experiment Video
Updated: Jan 31, 2026

04:54
Flavonoid Content During the Growth and Floral Development of Calendula officinalis L.
Published on: June 27, 2025
1.1K
[Antiplatelet activity of flavonoids]
1Altai State Medical University, Barnaul.
Voprosy Pitaniia
|December 29, 2018
Summary
Flavonoids, potent plant polyphenols, show promise in cardiovascular health by modulating platelet function. Further research is needed to translate in vitro findings into effective antiplatelet therapies.
Area of Science:
- Nutritional Biochemistry
- Cardiovascular Pharmacology
- Phytochemistry
Context:
- Cardiovascular diseases (CVDs) remain a leading cause of mortality worldwide.
- Dietary factors, particularly polyphenolic compounds like flavonoids, are increasingly recognized for their health benefits.
- Platelets play a critical role in hemostasis and thrombosis, making them key targets for CVD prevention.
Purpose:
- To review the influence of major food flavonoid subclasses on the organism.
- To discuss the role of flavonoids and flavonoid-rich foods in reducing cardiovascular disease risk.
- To analyze the mechanisms by which flavonoids affect platelet function, including activation, adherence, and aggregation.
Summary:
- Flavonoids, a diverse group of plant polyphenols found in food, exert significant effects on organismal health.
- Evidence suggests flavonoids can correct platelet abnormalities by interacting with various receptors and intracellular signaling pathways.
- These compounds influence key steps in platelet activation, such as calcium mobilization and signal transduction.
Impact:
- Flavonoids demonstrate potential as a basis for developing safe and effective antiplatelet agents.
- This research highlights the contribution of flavonoids to the treatment and prevention of cardiovascular diseases.
- Acknowledges the need for further in vivo studies to bridge the gap between in vitro findings and clinical application.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.3K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.3K
Co-activators and Co-repressors
8.6K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.6K
tRNA Activation
22.9K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
22.9K
Activation Energy
86.6K
Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
86.6K
Eukaryotic Transcription Activators
12.8K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.8K
Secondary Active Transport
137.8K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
137.8K

